GlassScriptPhysician profile
Charnele N Mathies
NPI 1073983771
$4,180.71
in general payments reported to CMS, 2019-2025
17 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8.67 · 2022: $428 · 2023: $1,345 · 2024: $1,253 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,744.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,576.58 | 2022-2025 | Epclusa, Biktarvy |
| Viiv Healthcare Company | $1,042.59 | 2022-2025 | Apretude, Cabenuva, Rukobia |
| Abbvie INC. | $538.46 | 2022-2025 | |
| Antares Pharma, INC. | $244.41 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $204.63 | 2022-2025 | Pifeltro, Delstrigo, Dificid |
| Phathom Pharmaceuticals, INC. | $140.28 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $102.00 | 2023-2024 | Wegovy |
| Alkermes, INC. | $89.67 | 2023-2024 | Aristada, Lybalvi |
| Theratechnologies INC. | $67.11 | 2024 | Trogarzo, Egrifta, Egrifta Sv |
| Axsome Therapeutics, INC. | $42.73 | 2023-2024 | Auvelity |
| Exact Sciences Corporation | $40.96 | 2025 | The Cologuard Plus Collection Kit |
| Indivior INC. | $19.94 | 2023 | Sublocade |
| Braeburn INC. | $17.80 | 2023 | Brixadi |
| Organon LLC | $16.18 | 2024 | |
| Lilly USA, LLC | $15.80 | 2023 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $12.90 | 2023 | |
| Genentech USA, INC. | $8.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charnele Mathies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.